270 related articles for article (PubMed ID: 28642120)
21. Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?
Kekre N; Tokessy M; Mallick R; McDiarmid S; Huebsch L; Bredeson C; Allan D; Tay J; Tinmouth A; Sheppard D
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1719-24. PubMed ID: 24099958
[TBL] [Abstract][Full Text] [Related]
22. A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation.
Gajewski JL; Johnson VV; Sandler SG; Sayegh A; Klumpp TR
Blood; 2008 Oct; 112(8):3036-47. PubMed ID: 18583566
[TBL] [Abstract][Full Text] [Related]
23. [Physicians' perception on taking care of Jehovah's witnesses].
Gouezec H; Lerenard I; Jan S; Bajeux E; Renaudier P; Mertes PM;
Transfus Clin Biol; 2016 Nov; 23(4):196-201. PubMed ID: 27634593
[TBL] [Abstract][Full Text] [Related]
24. Development and current use of in hematopoietic stem cell transplantation in children and adolescents in Poland: Report of the Polish pediatric study group for hematopoietic stem cell transplantation of the Polish society for pediatric oncology and hematology.
Wachowiak J; Chybicka A; Kowalczyk JR; Wysocki M; Goździk J; Gorczyńska E; Kałwak K; Styczyński J; Drabko K; Pieczonka A
Transfus Apher Sci; 2018 Jun; 57(3):316-322. PubMed ID: 29880247
[TBL] [Abstract][Full Text] [Related]
25. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
26. Liver transplantation in Jehovah's witnesses.
Detry O; Roover AD; Delwaide J; Kaba A; Joris J; Damas P; Lamy M; Honoré P; Meurisse M
Transpl Int; 2005 Aug; 18(8):929-36. PubMed ID: 16008742
[TBL] [Abstract][Full Text] [Related]
27. How to approach major surgery where patients refuse blood transfusion (including Jehovah's Witnesses).
Gohel MS; Bulbulia RA; Slim FJ; Poskitt KR; Whyman MR
Ann R Coll Surg Engl; 2005 Jan; 87(1):3-14. PubMed ID: 15720900
[TBL] [Abstract][Full Text] [Related]
28. Jehovah's witnesses, blood transfusions and transplantations.
Sarteschi LM
Transplant Proc; 2004 Apr; 36(3):499-501. PubMed ID: 15110571
[TBL] [Abstract][Full Text] [Related]
29. Reflections on Cultural Preferences and Internal Medicine: The Case of Jehovah's Witnesses and the Changing Thresholds for Blood Transfusions.
Sagy I; Jotkowitz A; Barski L
J Relig Health; 2017 Apr; 56(2):732-738. PubMed ID: 28035631
[TBL] [Abstract][Full Text] [Related]
30. Safety of cardiac surgery without blood transfusion: a retrospective study in Jehovah's Witness patients.
El Azab SR; Vrakking R; Verhage G; Rosseel PM
Anaesthesia; 2010 Apr; 65(4):348-52. PubMed ID: 20402872
[TBL] [Abstract][Full Text] [Related]
31. Management of Jehovah's Witness patients with haematological problems.
Nash MJ; Cohen H
Blood Rev; 2004 Sep; 18(3):211-7. PubMed ID: 15183904
[TBL] [Abstract][Full Text] [Related]
32. Jehovah's Witness patients within the German medical landscape.
Rajtar M
Anthropol Med; 2016 Aug; 23(2):172-87. PubMed ID: 27321252
[TBL] [Abstract][Full Text] [Related]
33. [Major surgery on Jehovah's Witnesses].
Høiseth LØ; Giercksky KE; Larsen SG; Kongsgaard U
Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2658-61. PubMed ID: 17057765
[TBL] [Abstract][Full Text] [Related]
34. Caring for the Jehovah's Witness Parturient.
Mason CL; Tran CK
Anesth Analg; 2015 Dec; 121(6):1564-9. PubMed ID: 26579658
[TBL] [Abstract][Full Text] [Related]
35. Bloodless Orthotopic Heart Transplantation in a Jehovah's Witness.
Dallas T; Welsby I; Bottiger B; Milano C; Daneshmand M; Guinn N
A A Case Rep; 2015 May; 4(10):140-2. PubMed ID: 25974419
[TBL] [Abstract][Full Text] [Related]
36. [Clinical aspects of packed red cell transfusion. Lessons learned from Jehovah's Witnesses?].
von Bormann B
Anaesthesist; 2007 Apr; 56(4):380-4. PubMed ID: 17356861
[TBL] [Abstract][Full Text] [Related]
37. Management of hemolytic anemia following allogeneic stem cell transplantation.
Holbro A; Passweg JR
Hematology Am Soc Hematol Educ Program; 2015; 2015():378-84. PubMed ID: 26637746
[TBL] [Abstract][Full Text] [Related]
38. Acute lymphoblastic leukaemia in a Jehovah's Witness: a management dilemma.
Zhou L; Mohsen A; Khan MA; Guthrie T
J Chemother; 2014 Jun; 26(3):184-6. PubMed ID: 24621157
[TBL] [Abstract][Full Text] [Related]
39. Is total hip arthroplasty a successful and safe procedure in Jehovah's Witnesses? Mean five-year results.
Harwin SF; Pivec R; Naziri Q; Issa K; Mont MA
Hip Int; 2014; 24(1):69-76. PubMed ID: 24318363
[TBL] [Abstract][Full Text] [Related]
40. Providing Hemostatic and Blood Conservation Options for Jehovah's Witness Patients in a Large Medical System.
Bai Y; Castillo BS; Tchakarov A; Escobar MA; Cotton BA; Holcomb JB; Brown RE
Ann Clin Lab Sci; 2016 Dec; 46(6):654-661. PubMed ID: 27993880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
